Huperzine A as add-on therapy in patients with treatment-resistant schizophrenia: an open-labeled trial.
Zhang
Zhang-Jin
ZJ
Tong
Yao
Y
Wang
Xue-Yi
XY
Yao
Shao-Min
SM
Jin
Gui-Xing
GX
Wang
Xiao-Ping
XP
D000293:Adolescent; D000328:Adult; D000368:Aged; D000470:Alkaloids; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D002746:Chlorpromazine / Q000378:metabolism / Q000627:therapeutic use*; D002800:Cholinesterase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D003024:Clozapine / Q000378:metabolism / Q000627:therapeutic use*; D004351:Drug Resistance; D004357:Drug Synergism; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D018967:Risperidone / Q000378:metabolism / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy*; D012717:Sesquiterpenes / Q000494:pharmacology / Q000627:therapeutic use*
D000470:Alkaloids; D014150:Antipsychotic Agents; D002800:Cholinesterase Inhibitors; D012717:Sesquiterpenes; C050426:huperzine A; D003024:Clozapine; D018967:Risperidone; D002746:Chlorpromazine